SEARCH

SEARCH BY CITATION

References

  • 1
    Woosley RL, Chen Y, Freiman JP, Gillis RA. Mechanisms of the cardiotoxic actions of terfenadine. JAMA 1993; 269: 15321536.
  • 2
    Pratt CM, Ruberg S, Morganroth J, et al. Dose–response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: Distinguishing a drug effect from spontaneous variability. Am Heart J 1996; 131: 472480.
  • 3
    Hurst M & Spencer CM. Ebastine. An update of its use in allergic disorders. Drugs 2000; 59: 9811006.
  • 4
    Moss AJ, Chaikin P, Garcia JD, Gillen M, Roberts DJ, Morganroth J. A review of the cardiac systemic side effects of antihistamines: ebastine. Clin Exp Allergy 1999; 29(Suppl 3): 200205.
  • 5
    Moss AJ & Morganroth J. Cardiac effects of ebastine and other antihistamines in humans. Drug Safety 1999; 21(Suppl 1): 6980.
  • 6
    Sale ME, Barby JT, Woosley RL, et al. The electrocardiographic effects of cetirizine in normal subjects. Clin Pharmacol Ther 1994; 56: 295301.
  • 7
    Bazett HC. An analysis of the time-relations of the electrocardiograms. Heart 1920; 7: 353370.
  • 8
    Fridericia LS. Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken. Acta Med Scand 1920; 53: 469486.
  • 9
    Woosley RL. Cardiac actions of antihistamines. Ann Rev Pharmacol Toxicol 1996; 36: 233252.
  • 10
    Funck-Brentano C & Jaillon P. Rate-corrected QT interval. techniques and limitations. Am J Cardiol 1993; 72: 17B22B.
  • 11
    Hodges M. Rate correction of the QT interval. Cardiac Electrophysiol Rev 1997; 3: 360363.
  • 12
    Elming H, Holm EL, Torp-Pedersen C, et al. The prognostic value to the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J 1998; 19: 13911400.DOI: 10.1053/euhj.1998.1094
  • 13
    Morganroth J, Brown AW, Critz S, et al. Variability of the QTc interval: impact on defining drug effect and low-frequency cardiac event. Am J Cardiol 1993; 72: 26B31B.